Phase II Study of Bevacizumab in Combination with Carboplatin plus oral S1 in Chemo-Naive Patients with Non-Squamous Non-Small-Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2013
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Gimeracil/oteracil/tegafur
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 02 Jun 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 30 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 21 Oct 2011 New trial record